| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |